UTRECHT, the Netherlands, April 5, 2017 /PRNewswire/ --
ViCentra is delighted to announce that Kaleido - its hotly-anticipatednew insulin delivery system - was awarded Bronze in the category 'Best visual identity from the healthcare and pharmaceutical sector' at last week's eighth annual Transform Awards Europe.
Established in 2009, the Transform Awards recognise
Judged this year by a panel of leading industry experts, the awards recognised Kaleido for its outstanding creative ability, strategic thought and development of a captivating brand that aims to help people with diabetes live life on their own terms.
"We're already incredibly proud of Kaleido, but I'm delighted that we're now officially award-winning too", said Amy Oakes, Head of Creative Engagement at ViCentra. "We've worked hard to create a brand that works for people who live with Type 1 diabetes - listening to and collaborating with them to shake things up in the diabetes industry and create a brand experience that's intentionally non-medical, personal and simple - just like our products. Kaleido is about far more than stunning visuals, it's about how we make people feel, allowing those who use Kaleido to take control and make the choices that are right for them, bringing personality to a therapy that has previously been overcomplicated, time-consuming and uninspiring."
The award also recognises ViCentra's close collaboration with London-based design agency, Nalla. Working with the ViCentra team, Nalla has created Kaleido's strategic brand positioning, naming and visual identities, and translated the brand identity across product, packaging and marketing collateral.
"I'm thrilled that Nalla have been recognised for their work on Kaleido, on what was a hugely successful night for them", Amy Oakes went on to say. "From the outset, we've felt as though our knowledge and desire to change the diabetes industry has informed their thinking, but also that their creativity and design instincts have in turn hugely shaped our approach too, something I think is very much reflected in the Kaleido brand".
Reflecting on the win, Vicki Young, Director and Founder of Nalla, said: "We are so proud to be recognised for our achievement. This would have not been possible without the aligned vision of ViCentra and Nalla along with the incredible collaborative relationship that was formed during the project. A relationship that we're pleased to see grow the more we work together."
Jonny Davidson, Senior Designer at Nalla, said: "It's so refreshing to work on a truly innovative product and forward-thinking company. They shared our passion for challenging the status quo and believed in our philosophy that brand is more than just a logo or set of colours - it's an experience that comprises every brand interaction with the user. With it still being early days, we're thrilled with the response and recognition that Kaleido has received so far."
The 2017 Transform Awards Europe celebrated entries from countries across Europe, including the Netherlands, UK, Sweden, France, Poland and beyond. With fierce competition, the caliber of entries this year broke all previous awards records, with a 35% increase in both the companies entering and the actual number of entries.
The awards ceremony, hosted by comedian and actor Russell Kane, was held at the Brewery, in Moorgate, London.
Notes to Editors
Not your average medical device brand, the Kaleido team are the friends and family of people who live with Type 1 diabetes. They understand that diabetes is inconsistent, inexact and - most importantly - it's individual. It's not a one-size-fits-all condition and they don't think insulin pumps should be either.
So, they've created Kaleido, an insulin pump designed to help people live life on their own terms. How? By making it personal, keeping things discreet (for those who like it that way!) and creating simple, easy-to-use products and services.
Kaleido will be commercially available in the Netherlands and UK in 2017. To stay up to date with all of Kaleido's latest news, check out the Kaleido website, http://www.hellokaleido.com, or follow along on Twitter (@HeyKaleido).
ViCentra was founded in 2013 with investments from INKEF Capital and Health Innovations. A further investment was made by LSP in 2016.
Based in the Netherlands, ViCentra believes that if healthcare products are simple to understand, beautiful to look at and deliver superb results, they are more enjoyable to use and more likely to help people achieve great things. ViCentra are creating healthcare products with this philosophy firmly in mind. They don't design for patients - they design for people. ViCentra's first product is Kaleido, a game-changing insulin delivery system for people living with Type 1 diabetes. More information about ViCentra can be found at http://www.ViCentra.com .
Nalla is an independent, award-winning branding agency, specialising in creating agile brands. They use strategic thinking and digital design to transform businesses in a fast paced digital world. Since 2010, they have worked across all sectors and collaborated with high-profile clients such as Waitrose, Informa, EY and Greene King. For more information, please go to http://www.nalla.co.uk.
Subscribe to our Free Newsletters!
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...View All